Docetaxel in the Treatment of Hormone Refractory Prostate Cancer

Clinical trial NCT00280098 · COMPLETED

Trial details

NCT number: NCT00280098
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2006-01-01
Primary completion: 2007-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.